| Literature DB >> 21455295 |
Yuan-Ping Pang1, Jewn Giew Park, Shaohua Wang, Anuradha Vummenthala, Rajesh K Mishra, John E McLaughlin, Rong Di, Jennifer Nielsen Kahn, Nilgun E Tumer, Laszlo Janosi, Jon Davis, Charles B Millard.
Abstract
Ribosome-inactivating proteins (RIPs) are toxic because they bind to 28S rREntities:
Mesh:
Substances:
Year: 2011 PMID: 21455295 PMCID: PMC3063779 DOI: 10.1371/journal.pone.0017883
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Known small-molecule inhibitors of ribosome-inactivating proteins.
Figure 2Tyr80 in crystal structures of ricin subunit A (RTA) in the bound and unbound states.
a (top left): overlay of the apo RTA (green, 1IFT [32]) with the oligonucleotide-bound RTA at the Michaelis-Menten state (yellow; 3HIO [13]) showing that the adenine group markedly perturbs the conformation of Tyr80; b (top right): three distinct conformations of Tyr80: conformations 1, 2, and 3 represent the apo conformation in green (1IFT [32]), the less populated bound conformation in magenta (1IFS [32]), and the most populated bound conformation in yellow (1FMP [31]), respectively; c (bottom left): the phenolic ring with an adenine group underneath and a docking box atop in the less populated bound conformation (1IFS [32]); d (bottom right): overlay of the oligonucleotide-bound RTA at the Michaelis-Menten state (yellow; 3HIO [13]) with RTA in conformation 1 (green; 1IFT [32]), conformation 2 (magenta; 1IFS [32]), and conformation 3 (cyan; 1FMP [31]) showing the closeness of the Tyr80 conformations in 3HIO and 1FMP and the clash between the nucleotide and Tyr80 in 1IFS.
Figure 3Chemical structures and binding modes of small-molecule inhibitors of ricin subunit A.
The complexes were generated using the EUDOC program with the 1IFS crystal structure [32]. The residues from left to right are Phe93, Tyr80, Arg258, and Arg213.
Figure 4Synthetic schemes for R16, R20, and R22.
Figure 5NOESY spectrum of R20 indicating the keto form and the Z stereochemistry.
Increase of rabbit reticulocyte lysate in vitro translation caused by exposure to 1 nM ribosome-inactivating protein inhibitor and 1 nM ricin subunit A (RTA) or 0.5 nM Shiga-like toxin 2 (Stx2) relative to the exposure to 1 nM RTA or 0.5 nM Stx2.
| Inhibitor | Translation (%) | Translation (%) | Fold | Translation (%) | Translation (%) | Fold |
| RTA | RTA+Inhibitor | Improvement | Stx2 | Stx2+Inhibitor | Improvement | |
|
| 32 | 34 | 1.1 | 35 | 38 | 1.1 |
|
| 30 | 48 | 1.6 | 35 | 48 | 1.4 |
|
| 32 | 36 | 1.1 | 35 | 43 | 1.2 |
|
| 30 | 51 | 1.7 | 35 | 46 | 1.3 |
|
| 30 | 47 | 1.6 | 35 | 44 | 1.3 |
|
| 30 | 48 | 1.6 | 35 | 38 | 1.1 |
|
| 32 | 38 | 1.2 | 35 | 46 | 1.3 |
|
| 30 | 41 | 1.4 | 35 | 47 | 1.3 |
|
| 30 | 42 | 1.4 | 35 | 44 | 1.3 |
Figure 6Concentration effects of R16b on the luciferase activity.
Figure 7Structural similarity of R16b to D-luciferin and 3-(5-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzoic acid.
Row 1: D-luciferin; Row 2: R16b; Row 3: 3-(5-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzoic acid; Row 4: overlay of R16b and 3-(5-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzoic acid; Row 5: R16b or D-luciferin bound in the active site of firefly luciferase. Conformations of R16b, D-luciferin, and 3-(5-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzoic acid in the free state were energy optimized by ab initio calculations at the HF/6-31G*//HF/6-31G* level using the Gaussian 98 program [62].
Figure 8Concentrational effect of R16b on the firefly luciferase (ffLuc) activity.
Upper panel: the activity of high-concentration ffLuc versus R16b concentration. Lower panel: the activity of low-concentration ffLuc versus R16b concentration.
Ex vivo inhibition of ribosome-inactivating proteins by R16, R19, R20, and R22 and their analogues at 0.3, 3.0, and 30.0 µM.
| Inhibitor | % cell protection (SD) by 0.3 µM inhibitor against ricin | % cell protection (SD) by 3.0 µM inhibitor against ricin | % cell protection (SD) by 30.0 µM inhibitor against ricin | % cell protection by 0.3 µM inhibitor against Stx2 |
|
| 13 (6) | 22 (5) | 21 (7) | 17 |
|
| 12 (6) | 16 (1) | 22 (2) | 11 |
|
| 13 (7) | 15 (4) | 16 (3) | 16 |
|
| 16 (5) | 19 (4) | 15 (2) | 11 |
|
| 15 (5) | 20 (2) | 18 (2) | 8 |
|
| 9 (5) | 13 (4) | 10 (5) | 3 |
|
| 5 (6) | 4 (3) | 8 (3) | 15 |
|
| 2 (9) | 4 (9) | 8 (6) | 6 |
|
| 1 (6) | 0 (4) | 1 (6) | 21 |
Figure 9Overlay of ricin subunit A (RTA) and Shiga-like toxin 2 subunit A1 (Stx2A1).
The RTA (green) and Stx2A1 (yellow) structures are taken from crystal structures of 1IFS [32] and 1R4P [50].